全身与前列腺多参数磁共振成像一步法同步评估根治性前列腺切除术后局部复发与转移性疾病
本研究为回顾性单中心研究,纳入76例根治性前列腺切除术后临床怀疑复发的前列腺癌患者,于单次检查中完成全身与专用前列腺磁共振成像。该联合成像在全部患者中成功完成,识别出16例(21%)疑似复发,并在43例有标准分期扫描对照的患者中显示36例(84%)一致性。结论认为该联合成像在临床实践环境中可行,相比标准影像可提供增量信息。
要点
- 联合全身与专用前列腺磁共振成像在76例术后怀疑复发患者中全部成功完成。
- 联合成像识别出16/76例(21%)疑似复发,包括局部6例、淋巴结3例、骨4例、多灶转移3例。
- 在43例有标准分期扫描对照的患者中,联合成像与标准影像一致36例(84%)。
核心结论
- 联合全身与专用前列腺磁共振成像在临床实践环境中可行,相比标准影像可为根治性前列腺切除术后怀疑复发的男性提供增量信息。
研究设计与样本
- 经机构审查委员会批准的回顾性单中心研究,纳入2014年10月至2016年1月连续76例根治性前列腺切除术后临床怀疑复发的前列腺癌患者,于单次 session 接受联合全身与专用前列腺磁共振成像。
主要发现
- 联合成像在全部76例患者中成功完成,中位前列腺特异性抗原为0.36 ng/ml(范围小于0.05至56.12)。
- 联合成像识别出16/76例(21%)疑似疾病复发,包括根治性前列腺切除床局部复发6例、淋巴结转移3例、骨转移4例和多灶转移性疾病3例。
- 43例患者除联合成像外至少进行了1项标准分期扫描,两种成像方式在36/43例(84%)中显示一致性。
- 其他影像检查检测到的所有转移灶均被磁共振成像检测到;磁共振成像还检测出4例其他影像假阴性患者的骨转移,包括2例骨扫描和3例计算机断层扫描。
- 磁共振成像排除了1例18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描阳性但后续骨活检阴性患者的骨病变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We report our initial experience with whole body and dedicated prostate magnetic resonance imaging as a single examination to assess local recurrence and metastatic disease in patients with suspected recurrent prostate cancer after radical prostatectomy. MATERIALS AND METHODS: In this institutional review board approved, retrospective, single center study 76 consecutive patients with clinically suspected recurrent prostate cancer following radical prostatectomy underwent combined whole body and dedicated prostate magnetic resonance imaging at a single session from October 2014 to January 2016. Scans were evaluated to detect disease in the prostate bed and regional nodes, and at distant sites. Comparison was made to other imaging tests, and prostate bed, node and bone biopsies performed within 90 days. RESULTS: Whole body and dedicated prostate magnetic resonance imaging was completed successfully in all patients. Median prostate specific antigen was 0.36 ng/ml (range less than 0.05 to 56.12). Whole body and dedicated prostate magnetic resonance imaging identified suspected disease recurrence in 16 of 76 patients (21%), including local recurrence in the radical prostatectomy bed in 6, nodal metastases in 3, osseous metastases in 4 and multifocal metastatic disease in 3. In 43 patients at least 1 standard staging scan was done in addition to whole body and dedicated prostate magnetic resonance imaging. Concordance was demonstrated between the imaging modalities in 36 of 43 cases (84%). All metastatic lesions detected by other imaging tests were detected on magnetic resonance imaging. In addition, the magnetic resonance imaging modality detected osseous metastases in 4 patients with false-negative findings on other imaging tests, including 2 bone scans and 3 computerized tomography scans. It also excluded osseous disease in 1 patient with positive 18F-fluorodeoxyglucose positron emission tomography/computerized tomography and subsequent negative bone biopsy. CONCLUSIONS: Combined whole body and dedicated prostate magnetic resonance imaging is feasible in a clinical practice setting. It can provide incremental information compared to standard imaging in men with suspected prostate cancer recurrence after radical prostatectomy.
引用
- Robertson NL, Sala E, Benz M, et al. Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy. J Urol. 2017. PMID: 28216327. doi:10.1016/j.juro.2017.02.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。